Case series · 1996
Paroxetine in the treatment of premature ejaculation
Ludovico GM, Corvasce A, Pagliarulo G, Cirillo-Marucco E, Marano A, Pagliarulo A (1996). Paroxetine in the treatment of premature ejaculation. British Journal of Urology. doi:10.1046/j.1464-410x.1996.02120.x
In 32 men given daily paroxetine for 2 months, all reported longer latency after about 14 days, but PE recurred in 28 of 32 men within three weeks of stopping.
Summary
This small Italian study treated 32 men (mean age 28) with premature ejaculation (PE) with paroxetine, a selective serotonin reuptake inhibitor (SSRI), 20 mg each evening for two months. Fourteen of them ejaculated before penetration. Men with neurological or psychiatric disorders, urinary tract infections or drug or alcohol misuse were excluded.
After about 14 days, all men reported a longer interval before ejaculation. Side effects were common: sleepiness in 19 men (61%) and mild sensory confusion in 21 (68%), although only one stopped treatment. Three weeks after the end of therapy, PE had come back in 28 men (90%, as reported by the authors).
Limitations
There was no control group and no blinding, the sample was small, and latency was self-reported. The percentages in the abstract are reported as given by the authors.
What it means for you
For most men, the delaying effect of an SSRI lasts only as long as they take it. If you stop, expect timing to drift back towards your baseline within weeks, and plan for that with your doctor.